Search Results - Ourfali, Saïd

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    TL-532, a novel specific Toll-like receptor 3 agonist rationally designed for targeting cancers: discovery process and biological characterization

    TL-532, a novel specific Toll-like receptor 3 agonist rationally designed for targeting cancers: discovery process and biological characterization by Thierry, Sylvain, Maadadi, Sarah, Berton, Aurore, Dimier, Laura, Perret, Clémence, Vey, Nelly, Ourfali, Saïd, Saccas, Mathilde, Caron, Solène, Boucard-Jourdin, Mathilde, Colombel, Marc, Werle, Bettina, Bonnin, Marc

    Published in Microbial cell
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Re: Primary Chemoablation of Low-grade Upper Tract Urothelial Carcinoma Using UGN-101, a Mitomycin-containing Reverse Thermal Gel (OLYMPUS): An Open-label, Single-arm, Phase 3 Trial

    Re: Primary Chemoablation of Low-grade Upper Tract Urothelial Carcinoma Using UGN-101, a Mitomycin-containing Reverse Thermal Gel (OLYMPUS): An Open-label, Single-arm, Phase 3 Tria... by Ourfali, Said, Colombel, Marc

    Published in European urology
    Get full text
    Items that this one cites
    Article
    Save to List
    Saved in:
  3. 3
    Lymphatic embolization for the management of symptomatic pelvic lymphocele after radical prostatectomy with lymph node dissection: Report of two cases

    Lymphatic embolization for the management of symptomatic pelvic lymphocele after radical prostatectomy with lymph node dissection: Report of two cases by Schneider, Gregoire, Ourfali, Said, Rouviere, Olivier, Pagnoux, Gaele, Colombel, Marc

    Published in IJU case reports
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  4. 4
    Abstract 2085: The specific TLR3-agonist TL-532 induces life-long anti-tumor autovaccination, cross-immunity against unrelated cancers and reverses resistance to immune checkpoint inhibitors

    Abstract 2085: The specific TLR3-agonist TL-532 induces life-long anti-tumor autovaccination, cross-immunity against unrelated cancers and reverses resistance to immune checkpoint... by Bonnin, Marc, Ourfali, Saïd, Boucard-Jourdin, Mathilde, Perret, Clémence, Renoux, Chloé, Vey, Nelly, Colombel, Marc, Werlé, Bettina, Thierry, Sylvain

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Recurrence Rate and Cost Consequence of the Shortage of Bacillus Calmette-Guérin Connaught Strain for Bladder Cancer Patients

    Recurrence Rate and Cost Consequence of the Shortage of Bacillus Calmette-Guérin Connaught Strain for Bladder Cancer Patients by Ourfali, Said, Ohannessian, Robin, Fassi-Fehri, Hakim, Pages, Alfreda, Badet, Lionel, Colombel, Marc

    Published in European urology focus
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  6. 6
    Prognostic Implications of Treatment Delays for Patients with Non–muscle-invasive Bladder Cancer

    Prognostic Implications of Treatment Delays for Patients with Non–muscle-invasive Bladder Cancer by Ourfali, Said, Matillon, Xavier, Ricci, Estelle, Fassi-Fehri, Hakim, Benoit-Janin, Mélanie, Badet, Lionel, Colombel, Marc

    Published in European urology focus
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  7. 7
    Lymphatic embolization for the management of symptomatic pelvic lymphocele after radical prostatectomy with lymph node dissection: Report of two cases

    Lymphatic embolization for the management of symptomatic pelvic lymphocele after radical prostatectomy with lymph node dissection: Report of two cases by Schneider, Gregoire, Ourfali, Said, Rouviere, Olivier, Pagnoux, Gaele, Colombel, Marc

    Published in IJU case reports
    Get full text
    Report
    Save to List
    Saved in:

Search Tools: